Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating the triptans.

Ninan T Mathew1, Elizabeth W Loder

  • 1Houston Headache Clinic, and Department of Neurology, University of Texas Medical School, Houston, Texas 77004, USA. ntmathew@houstonheadacheclinic.com

The American Journal of Medicine
|April 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strengthening the reporting of observational studies in epidemiology using Mendelian randomization (STROBE-MR): a Korean translation of explanation and elaboration.

Ewha medical journal·2025
Same author

Reporting Guideline for Chatbot Health Advice Studies: The CHART Statement.

JAMA network open·2025
Same author

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods: a Korean translation.

Ewha medical journal·2025
Same author

Disagreement with categorization of clinical trials included in Treadwell et al. systematic review and meta-analysis.

Headache·2025
Same author

Calcitonin Gene-Related Peptide Inhibition and Development of Acne and Rosacea.

JAMA dermatology·2024
Same author

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.

BMJ (Clinical research ed.)·2024
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026
Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026
See all related articles

Second-generation oral triptans offer improved migraine relief compared to older treatments. Understanding individual triptan pharmacokinetics is key for healthcare providers to select optimal migraine therapy for patients.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine treatment seeks agents targeting characteristic and associated symptoms.
  • Second-generation oral triptans demonstrate enhanced efficacy over sumatriptan and traditional analgesics.

Purpose of the Study:

  • To review clinical trial data comparing triptan efficacy and pharmacokinetic properties.
  • To guide healthcare providers in selecting individualized migraine pharmacotherapy.

Main Methods:

  • Review of published comparator trials on triptans.
  • Analysis of commonly used efficacy endpoints and pharmacokinetic properties.
  • Focus on patient-preferred outcomes like rapid onset and sustained pain relief.

Main Results:

  • Second-generation triptans show improved efficacy profiles.

Related Experiment Videos

  • Distinct pharmacokinetic properties influence individual triptan efficacy and tolerability.
  • Patient preference for rapid-acting, complete pain relief without recurrence.

    • Conclusions:

    • Healthcare providers must consider individual patient needs when choosing triptans.
    • Pharmacology and clinical data guide the selection of optimal migraine treatments.
    • Individualized pharmacotherapy selection is crucial for effective migraine management.